Trademark: ONGLYZA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ONGLYZA
We do not have any records of a proof of use for ONGLYZA at this moment.
Possible trademark infringements of ONGLYZA
Basic Information about ONGLYZA
- Serial Number
- 78791308
- Filing Date
- 13 Jan 2006
- Registration Number
- 3723838
- Registration Date
- 08 Dec 2009
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of ONGLYZA on the blockchain with WikiTrademarks.io.
- First use of ONGLYZA anywhere
- ONGLYZA was first used on 31 Jul 2009 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns ONGLYZA?
1. ASTRAZENECA AB Södertälje
2. Bristol-Myers Squibb Company New York NY
3. Bristol-Myers Squibb Company New York NY
4. Bristol-Myers Squibb Company New York NY
Correspondent
- Cara M. Kearney
- AstraZeneca Pharmaceuticals LP
- 1800 Concord Pike, A2C
- Wilmington DE 19850-5437
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io